lURIE CANCER CENTER AND Northwestern Medicine
EXPERTS AT THE 2025 ASTRO Annual Meeting
Physicians and scientists from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Northwestern Medicine will present and discuss on top-tier science and education in radiation oncology at the 67th ASTRO Annual Meeting held at the Moscone Center in San Francisco from September 27 – October 1, 2025.
a sample of our presentation schedule
|
Presenter
|
Date, Time & Location
|
Track & Session
|
|
Poonam Yadav, PhD, research associate professor of Radiation Oncology at Northwestern Medicine
|
Sunday, September 28, 2025
2:30 - 4:00 pm PT Hall F, Screen 17 |
PQA 01 - Radiation and Cancer Physics, Sarcoma and Cutaneous Tumors
2277 - Dose Rate Dependence of Rbe of I-125 in Eye Plaque Treatment |
|
Qian Zhang, MD, PhD, current chief resident of Radiation Oncology at Northwestern Medicine
|
|
|
|
Tuesday, September 30, 2025
4:00 - 5:00 pm PT Hall F, Screen 8 |
PQA 09 - Hematologic Malignancies, Health Services Research, Digital Health Innovation and Informatics
3758 - Microsoft Copilot's Performance in Extracting Variables about Radiation Oncology Breast Cancer Articles |
|
Monday, September 29, 2025
8:30 - 8:40 am PT Room 22/23 |
SS 15 - Radiation Biology 2: Novel Immunotherapeutics & Biomarker Discovery
191 - Preclinical Evaluation of First-in-Class PROTAC Survivin Degrader HMAK101 for Radiosensitization for GBM, DIPG and Brain Metastases |
|
Michelle Kwan, medical student at Northwestern University Feinberg School of Medicine
|
Monday, September 29, 2025
10:45 am - 12:00 pm PT Hall F, Screen 1 |
PQA 04 - Gynecological Cancer, Head and Neck Cancer
2784 - Outcomes of HPV-Positive Oropharyngeal Cancer in Smokers vs. Non-Smokers |
|
Monday, September 29, 2025
2:42 - 2:52 pm PT San Francisco Ballroom |
PL 01 - Plenary
LBA 03 - Tumor Treating Fields (TTFields) After Stereotactic Radiosurgery (SRS) for Brain Metastases from Non-Small Cell Lung Cancer (NSCLC BM): Final Results of The Phase 3 METIS Trial |
|
Monday, September 29, 2025
3:15 - 3:20 pm PT Room 159 |
QP 03 - HSR 1: Quick Pitch: From Data to Delivery: Health Services Insights in Radiation Oncology
1014 - Predictors of Bad Debt in Patients Undergoing Radiotherapy |
|
Tuesday, September 30, 2025
4:00 - 5:00 pm PT Hall F, Screen 8 |
PQA 09 - Hematologic Malignancies, Health Services Research, Digital Health Innovation and Informatics
3668 - Application of Large Language Models for Condensation of Oncopathological Reports for Clinical Use |
|
Sagnik Sarkar, medical student at Northwestern University Feinberg School of Medicine
|
Tuesday, September 30, 2025
4:00 - 5:00 pm PT Hall F, Screen 8 |
PQA 09 - Hematologic Malignancies, Health Services Research, Digital Health Innovation and Informatics
3718 - Explainable Federated Learning for Plan Quality Assurance (QA) Prediction across Anatomical Sites |
|
Sean Sachdev, MD, vice chair of education and associate professor of Radiation Oncology at Northwestern Medicine
|
Wednesday, October 1, 2025
8:00 - 9:00 am PT Room 155/157 |
QP 20 - GU 9: Quick Pitch: Predictive Markers in Prostate Cancer
*followed by question and answer session led by Dr. Sachdev at 8:35 - 8:55 am PT |
connect with us on social
Use #ASTRO25 to follow and share insights from the meeting on Twitter, tagging:
- Lurie Cancer Center: @LurieCancer
- Northwestern Medicine: @NorthwesternMed
NORTHWESTERN MEDICINE onCOLOGY
|
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital is a global leader in the treatment of a broad range of cancer types due to its dedication to comprehensive clinical oncology research, world-renowned faculty, physicians and oncologists, and its commitment to making breakthroughs in medical, surgical, radiation and interventional oncology. The Lurie Cancer Center is designated by the National Cancer Institute as one of only 57 comprehensive cancer centers in the nation recognized for their scientific leadership, resources and the depth and breadth of their research. In addition, Lurie Cancer Center is a founding member of the National Comprehensive Cancer Network (NCCN) and our physicians actively participate in writing NCCN patient guidelines for each type cancer.
|